Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy.
暂无分享，去创建一个
O. Cummings | P. Albers | J. Donohue | R. Foster | M. Boris | J. Albers
[1] J. Richie,et al. The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989). , 1995, The Journal of urology.
[2] P. Albers,et al. Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors , 1994, Cancer.
[3] J. Thornhill,et al. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989. , 1993, British journal of urology.
[4] D. Stablein,et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. , 1987, The New England journal of medicine.